which’s been a busy week for AliveCor.
The Qualcomm-backed start-up’s claim to fame is actually its tiny electrocardiogram, which tucks into a custom Apple Watch band as well as screens for atrial fibrillation, a leading cause of strokes. which also recruited a prominent CEO in Vic Gundotra, the former senior vice president of engineering at Google.
Earlier which week, which reached a big milestone when the Food as well as Drug Administration gave which “breakthrough device designation” to use its EKG to screen for elevated potassium levels without requiring any blood.
as well as then Apple happened.
On Wednesday, the company announced which which had developed its own EKG for the Apple Watch, potentially replacing the AliveCor one. as well as its EKG sensor as well as apps had clearance via the FDA to provide consumers with access to their EKG readings immediately (in AliveCor’s case, a doctor reviews which for free within 24 hours to unlock the first reading).
which left many wondering what could happen to AliveCor.
nevertheless Gundotra told CNBC which Apple gave his start-up its biggest boost yet.
Before Apple spoke about which on stage, Gundotra said many people had never even heard of an EKG, let alone bought one. from the wake of Apple’s event, he said, AliveCor has seen a doubling in traffic to its website as well as an 80 percent jump in sales for its portable EKGs.
which’s possible which AliveCor, which is actually backed by more than $40 million in venture capital, could take a bigger hit when Apple launches the EKG as well as its mobile apps later which year. nevertheless for today, Gundotra says, the company is actually profiting via the attention. He also makes the case which his company’s devices are available for just $99 as well as up, while the Series 4 of the Apple Watch starts at $399.
“I’m thrilled,” said Gundotra. “We have a lot less explaining to do.”